Bristol Myers Squibb Foundation – Startup Investor Profile

Bristol Myers Squibb Foundation is to promote health equity and improve the health outcomes of populations.

Location: New York

Country:

Investment Regions:

Investment Stages: late-stage, pre-seed, seed, series-a

Website: https://www.bms.com/about-us/responsibility/bristol-myers-squibb-foundation.html

AI Reasoning: I found multiple recent grants by the Bristol Myers Squibb Foundation on bms.com and related press pages. The foundation awarded grants reported on November 26, 2024 (e.g., $6.8M QUILS grant to University of Kentucky Markey Cancer Center and University of Colorado Cancer Center; $2.5M to UCLA Health for CAL-PALS). The most recent documented grant activity on the foundation’s site is November 26, 2024, which is 11 months and some days before the evaluation date – within the 12-to-6-month window? Actually November 26, 2024 is 11 months and 6 days prior to the evaluation date, which places the last known investment between 12 and 6 months ago. The correct classification given the definitions is “low-active”. However, additional BMS Foundation pages show grants dated April 2025 and other mentions, for example a page dated April 25, 2025 about lung cancer screening initiatives referencing recent grants; April 2025 is 6 months and a few days before the evaluation date, placing it within the 6-to-3 months window, which corresponds to “active”. The most recent concrete dated grant page is April 25, 2025 (recipient: University of Kentucky Markey Cancer Center, University of Colorado Cancer Center, UCLA Health, and others). Therefore, the appropriate tag is “active”.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.